Eddie Blair, CEO, GeneFirst, a biotech in the business of modernising molecular diagnostics, spoke to me about his funding strategy and how he is addressing the challenges. He is using…
Finding VC capital for your early stage biotech is not easy. I’ve been asking a few VC’s what single thing they’d want from biotech’s. Here’s the feedback: Get your pitch…
It is proving harder and harder for early stage biotech’s in the UK to get funding from VCs. Many are hoping high net worth individuals can fill the void. I…
Whether your searching for VC capital, appealing to generalist investors or looking for new pharma partners, you need to be able to tell your story effectively. I’ve been asking a…
I interviewed Malcom Young, CEO, e-therapeutics and asked him his secret to success in raising capital for his biotech. Here’s the gist. Learn to present your upside potential and manage…
Tim Mitchell, CEO, Sareum, an AIM listed biotech, spoke to me about his fears for the UK biotech industry. What he had to say was quite revealing. Understanding the investment…
Malcolm Young, CEO of e-therapeutics and a network pharmacologist, spoke to me about his concerns for the industry. Out of all of them, one stood out in particular. Understanding the…
Partnerships are the lifeblood of the biopharma industry. Understanding what makes them work can mean the difference between disaster and blockbuster success for biotech and pharma alike. So, I’ve been…
